Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Current Assets (2016 - 2025)

Sanara MedTech's Current Assets history spans 15 years, with the latest figure at $33.5 million for Q4 2025.

  • For Q4 2025, Current Assets rose 0.71% year-over-year to $33.5 million; the TTM value through Dec 2025 reached $33.5 million, up 0.71%, while the annual FY2025 figure was $33.5 million, 0.71% up from the prior year.
  • Current Assets reached $33.5 million in Q4 2025 per SMTI's latest filing, up from $31.2 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $36.8 million in Q1 2025 to a low of $17.2 million in Q1 2024.
  • Average Current Assets over 5 years is $25.5 million, with a median of $23.6 million recorded in 2021.
  • Peak YoY movement for Current Assets: soared 449.01% in 2021, then tumbled 31.44% in 2022.
  • A 5-year view of Current Assets shows it stood at $24.6 million in 2021, then dropped by 16.22% to $20.6 million in 2022, then fell by 7.81% to $19.0 million in 2023, then skyrocketed by 75.24% to $33.3 million in 2024, then rose by 0.71% to $33.5 million in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Current Assets are $33.5 million (Q4 2025), $31.2 million (Q3 2025), and $33.7 million (Q2 2025).